REDWOOD CITY, Calif. (AP) – Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and …
Threshold Pharmaceuticals 3Q loss widens on costs

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. Unexplained liver hemorrhage after metastasis radiofrequency ablation
  2. Affymax Q3 Loss Narrows – Update – RTT News
  3. Amylin, Takeda sign deal on weight-loss drugs – San Diego Union Tribune